deltatrials
Completed PHASE4 NCT00159848

Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra

Effectiveness Of An Educational Program To Improve Patients' Satisfaction Regarding Their Management Of Erectile Dysfunction With Sildenafil

Sponsor: Pfizer

Conditions Impotence
Interventions Treatment Optimization Program (educational material)
Updated 6 times since 2017 Last updated: May 2, 2013 Started: Sep 30, 2003 Primary completion: Sep 30, 2003 Completion: Sep 30, 2003

Listed as NCT00159848, this PHASE4 trial focuses on Impotence and remains completed. Sponsored by Pfizer, it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pfizer
Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.